Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Non-Hematological Cancer Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Non-Hematological Cancer Treatmentmarket, defines the market attractiveness level of Non-Hematological Cancer Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Non-Hematological Cancer Treatment industry, describes the types of Non-Hematological Cancer Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Non-Hematological Cancer Treatment market and the development prospects and opportunities of Non-Hematological Cancer Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Non-Hematological Cancer Treatment market in Chapter 13.
By Player:
Bristol-Myers Squibb
Amgen
Pfizer
Roche
Astellas Pharma
Novartis
Johnson & Johnson
By Type:
Chemotherapy
Surgery
Radiation Therapy
Others
By End-User:
Hospitals
Oncology Treatment Centre
Ambulatory Surgery Centers
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Non-Hematological Cancer Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Non-Hematological Cancer Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Non-Hematological Cancer Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Non-Hematological Cancer Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Non-Hematological Cancer Treatment Market Analysis and Outlook to 2022
-
7.1 Global Non-Hematological Cancer Treatment Consumption (2017-2022)
-
7.2 United States Non-Hematological Cancer Treatment Consumption (2017-2022)
-
7.3 Europe Non-Hematological Cancer Treatment Consumption (2017-2022)
-
7.4 China Non-Hematological Cancer Treatment Consumption (2017-2022)
-
7.5 Japan Non-Hematological Cancer Treatment Consumption (2017-2022)
-
7.6 India Non-Hematological Cancer Treatment Consumption (2017-2022)
-
7.7 South Korea Non-Hematological Cancer Treatment Consumption (2017-2022)
8 Region and Country-wise Non-Hematological Cancer Treatment Market Analysis and Outlook to 2028
-
8.1 Global Non-Hematological Cancer Treatment Consumption Forecast (2022-2028)
-
8.2 United States Non-Hematological Cancer Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Non-Hematological Cancer Treatment Consumption Forecast (2022-2028)
-
8.4 China Non-Hematological Cancer Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Non-Hematological Cancer Treatment Consumption Forecast (2022-2028)
-
8.6 India Non-Hematological Cancer Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Non-Hematological Cancer Treatment Consumption Forecast (2022-2028)
9 Global Non-Hematological Cancer Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Non-Hematological Cancer Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Surgery Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Non-Hematological Cancer Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oncology Treatment Centre Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ambulatory Surgery Centers Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Non-Hematological Cancer Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Non-Hematological Cancer Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Non-Hematological Cancer Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Oncology Treatment Centre Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Ambulatory Surgery Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Non-Hematological Cancer Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Non-Hematological Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Non-Hematological Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Non-Hematological Cancer Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Non-Hematological Cancer Treatment Market Competitive Analysis
-
14.1 Bristol-Myers Squibb
-
14.1.1 Bristol-Myers Squibb Company Details
-
14.1.2 Bristol-Myers Squibb Non-Hematological Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bristol-Myers Squibb Non-Hematological Cancer Treatment Product and Service
-
14.2 Amgen
-
14.2.1 Amgen Company Details
-
14.2.2 Amgen Non-Hematological Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Amgen Non-Hematological Cancer Treatment Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Non-Hematological Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Non-Hematological Cancer Treatment Product and Service
-
14.4 Roche
-
14.4.1 Roche Company Details
-
14.4.2 Roche Non-Hematological Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Roche Non-Hematological Cancer Treatment Product and Service
-
14.5 Astellas Pharma
-
14.5.1 Astellas Pharma Company Details
-
14.5.2 Astellas Pharma Non-Hematological Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Astellas Pharma Non-Hematological Cancer Treatment Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Non-Hematological Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Non-Hematological Cancer Treatment Product and Service
-
14.7 Johnson & Johnson
-
14.7.1 Johnson & Johnson Company Details
-
14.7.2 Johnson & Johnson Non-Hematological Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Johnson & Johnson Non-Hematological Cancer Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Non-Hematological Cancer Treatment
-
Figure Non-Hematological Cancer Treatment Picture
-
Table Global Non-Hematological Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Non-Hematological Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Non-Hematological Cancer Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Non-Hematological Cancer Treatment Consumption by Country (2017-2022)
-
Figure United States Non-Hematological Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Non-Hematological Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Non-Hematological Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Non-Hematological Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Non-Hematological Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Non-Hematological Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Hematological Cancer Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Non-Hematological Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Non-Hematological Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Non-Hematological Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Non-Hematological Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Non-Hematological Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Non-Hematological Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Surgery Consumption and Growth Rate (2017-2022)
-
Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Treatment Centre Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Surgery Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Treatment Centre Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Surgery Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Non-Hematological Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Non-Hematological Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Non-Hematological Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Non-Hematological Cancer Treatment Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Non-Hematological Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Non-Hematological Cancer Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Non-Hematological Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Non-Hematological Cancer Treatment Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Non-Hematological Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Non-Hematological Cancer Treatment Product and Service
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Non-Hematological Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Non-Hematological Cancer Treatment Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Non-Hematological Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Non-Hematological Cancer Treatment Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Non-Hematological Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Non-Hematological Cancer Treatment Product and Service
-
